Prescription opioid behaviors among adults with and without disabilities – United States, 2015–2016

Lauer, Eric A.; Henly, Megan; Brucker, Debra L.

doi:10.1016/j.dhjo.2018.12.001

Cited by 29 publications

(11 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Drug overdose deaths rose in 2020, driven by synthetic opioids. §§§§ Consistent with previous research, adults with disabilities disproportionately reported opioid use and nonopioid prescription drug misuse ( 8 ), highlighting the importance of educating patients and ensuring clinician access to prescription drug monitoring programs. ¶¶¶¶ Nearly one in ten adults with disabilities reported past-month opioid use, and opioid use among adults without disabilities increased.…”

Section: Discussionsupporting

confidence: 71%

Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021

Czeisler¹,

Board²,

Thierry³

et al. 2021

MMWR Morb. Mortal. Wkly. Rep.

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 71%

Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021

Czeisler¹,

Board²,

Thierry³

et al. 2021

MMWR Morb. Mortal. Wkly. Rep.

View full text Add to dashboard Cite

“…Despite the high rates of opioid use in the Medicare population entitled for disability, research 24,25 shows lower utilization of opioid treatment programs. This population is heterogeneous, with physical and cognitive disorders present at birth along with conditions acquired later in life.…”

Section: Discussionmentioning

confidence: 99%

Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults

Kuo

Raji

2019

JAMA Netw Open

View full text Add to dashboard Cite

Key PointsQuestionWhat is the rate of opioid overdose deaths among Medicare enrollees younger than 65 years who qualified for Medicare because of disability?FindingsIn this cohort study, the 1 766 790 adult Medicare enrollees who qualified for disability—representing 14.9% of the Medicare population—accounted for 80.8% of all opioid overdose deaths among all Medicare enrollees. Among the 11.1% of the enrollees with disability who had 3 co-occurring conditions of substance abuse, psychiatric diseases, and chronic pain syndrome, the opioid overdose death rate was 23.4 times higher than that for enrollees without any of the conditions.MeaningUnderstanding the heterogeneity of medical and psychiatric conditions associated with opioid use and misuse is key to developing specific, data-driven interventions targeted for each subgroup of high-risk populations.

show abstract

“…In addition, disability may create practical barriers to substance use disorder treatment. For example, people with disabilities are less likely to receive medications for OUD ( 97 ). Disability may also create barriers to participation in work activities, thereby worsening socioeconomic status ( 37 , 69 ), social connectedness ( 69 , 162 ), and emotional well-being ( 148 , 162 ) and ultimately increasing the risk of nonmedical opioid use ( 108 , 113 , 168 ).…”

Section: An Overview Of Social and Behavioral Contributors To The Ove...mentioning

confidence: 99%

A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic

Cerdá

Krawczyk

Hamilton

et al. 2021

Annu. Rev. Public Health

View full text Add to dashboard Cite

More than 750,000 people in the United States died from an overdose between 1999 and 2018; two-thirds of those deaths involved an opioid. In this review, we present trends in opioid overdose rates during this period and discuss how the proliferation of opioid prescribing to treat chronic pain, changes in the heroin and illegally manufactured opioid synthetics markets, and social factors, including deindustrialization and concentrated poverty, contributed to the rise of the overdose epidemic. We also examine how current policies implemented to address the overdose epidemic may have contributed to reducing prescription opioid overdoses but increased overdoses involving illegal opioids. Finally, we identify new directions for research to understand the causes and solutions to this critical public health problem, including research on heterogeneous policy effects across social groups, effective approaches to reduce overdoses of illegal opioids, and the role of social contexts in shaping policy implementation and impact. Expected final online publication date for the Annual Review of Public Health, Volume 42 is April 1, 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

show abstract

Prescription opioid behaviors among adults with and without disabilities – United States, 2015–2016

Cited by 29 publications

References 8 publications

Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021

Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021

Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults

A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic

Contact Info

Product

Resources

About